SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed 		Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc, zoomboom
Search This Board: 
Last Post: 6/22/2017 1:47:17 PM - Followers: 686 - Board type: Free - Posts Today: 1

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.
 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.
ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in Facebook, Twitter, LinkedIn & Google+
 
                                                                                       
 

NEWS


Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 
ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3		  
 
 
 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111
 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 
info@amarantus.com
pr@amarantus.com

Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com


IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475
ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 
 
 
                                                                            

 

AMBS
Current Price
Volume:
Bid Ask Day's Range
AMBS Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS News: Statement of Changes in Beneficial Ownership (4) 05/15/2017 12:09:57 PM
AMBS News: Current Report Filing (8-k) 05/09/2017 04:17:24 PM
AMBS News: Statement of Changes in Beneficial Ownership (4) 05/05/2017 04:58:34 PM
AMBS News: Current Report Filing (8-k) 04/17/2017 04:29:46 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 04/06/2017 09:03:57 AM
PostSubject
#126368   PMO and TRIX performed a crossover today. jjr04001 06/21/17 04:12:59 PM
#126367   this may well be a major step in JPetroInc 06/21/17 03:03:31 PM
#126366   Gerald signed today's 8K filed by Avant Diagnostics MikeCr 06/21/17 10:24:28 AM
#126365   Gipper everything you say about Gerald Commissiong is JPetroInc 06/20/17 08:48:59 PM
#126364   JP does it really matter. The man the gipper 06/20/17 08:28:09 AM
#126363   will Gerald address AMBS shareholders on 6/25 JPetroInc 06/19/17 08:28:13 PM
#126360   congratulations Fred JPetroInc 06/17/17 08:56:06 AM
#126358   You are correct that he is no angel, jjr04001 06/16/17 09:18:29 PM
#126357   freegriff - this security is an utter travesty JPetroInc 06/16/17 02:58:01 PM
#126356   you answered a lot of questions I didn't freegriff 06/16/17 11:13:33 AM
#126355   want real exaggeration - read Gerald's CEO Blogs, JPetroInc 06/16/17 09:53:02 AM
#126354   I wasn't correcting grammar, I was pointing out jjr04001 06/16/17 09:22:43 AM
#126352   Why would Josh Sason allow AMBS to file JPetroInc 06/16/17 08:31:46 AM
#126350   to be clear, even if actions were taken freegriff 06/16/17 12:28:05 AM
#126349   Based on the resistance created in January 2016. jjr04001 06/15/17 10:09:04 PM
#126348   boy CEO Gerald has had 2 years to JPetroInc 06/15/17 04:19:35 PM
#126347   what's that $0.625 pps based on again? JPetroInc 06/15/17 04:14:12 PM
#126346   Peeps dumping shares bigley at $0.02 JPetroInc 06/15/17 02:36:21 PM
#126345   floats aprox. 80-Mil. JPetroInc 06/15/17 08:31:08 AM
#126344   $0.6, or rather $0.625 to be more precise. jjr04001 06/14/17 09:40:05 PM
#126343   is that $0.60 or $0.06 JPetroInc 06/14/17 09:21:57 PM
#126342   .6 coming imo $AMBS jjr04001 06/14/17 04:29:37 PM
#126341   what's the target ?? JPetroInc 06/14/17 04:07:27 PM
#126340   Load the boat, another explosion is coming $$$ jjr04001 06/14/17 03:37:59 PM
#126339   hows that "on-going negotiation with all parties" going? JPetroInc 06/13/17 08:26:52 PM
#126337   Gerald's 'brilliant' decision to save $80k by going JPetroInc 06/10/17 02:48:26 PM
#126336   ...worked the 'inside short from offshore' on JPetroInc 06/10/17 08:56:39 AM
#126335   where's Ravi Kiron now? JPetroInc 06/09/17 10:42:56 PM
#126334   We shall see what D&D, Mr Chang and/or JPetroInc 06/08/17 09:53:54 AM
#126333   ...Amarantus progress on fulfillment and CHF evaluation of freegriff 06/08/17 09:38:15 AM
#126332   Amarantus's complete fulfillment of the terms & conditions JPetroInc 06/08/17 09:07:32 AM
#126331   you keep saying LOI withdrawl. Did you not freegriff 06/08/17 08:55:15 AM
#126330   Weekly TA Chart JPetroInc 06/07/17 10:08:07 PM
#126329   money's nothing to do with Amarantus JPetroInc 06/06/17 11:22:00 AM
#126327   any doubts about current LOI status on Amarantus JPetroInc 06/06/17 10:05:23 AM
#126326   Anyone still here has suffered greatly by AMBS's JPetroInc 06/05/17 08:21:58 AM
#126325   Avant is and was as much a joke SidVicious 06/04/17 06:29:01 PM
#126324   Anyone knows what's going on with Avant Diagnostics MikeCr 06/04/17 05:32:00 PM
#126323   Gerald states "AMBS's IP is worth $9-Bil. JPetroInc 06/04/17 01:19:21 PM
#126322   averaging down has its risks - AMBS shares JPetroInc 06/04/17 01:14:40 PM
#126321   well spoken.... JPetroInc 06/04/17 11:12:44 AM
#126320   JP, I think chances are low the LOI freegriff 06/04/17 10:55:08 AM
#126317   GO GERALD GO.... JPetroInc 06/02/17 11:57:13 AM
#126316   you are correct - I only wish it JPetroInc 06/01/17 08:35:03 PM
#126315   Ascendant Partners update today JPetroInc 06/01/17 04:23:37 PM
#126314   Gerald even bold-face lied about NuroPro JPetroInc 05/31/17 11:51:12 PM
#126312   if AMBS Management fails to obtain requisite $2.5-Mil JPetroInc 05/31/17 09:36:06 PM
#126311   94000 shares traded today. No one posted. This joboggi 05/31/17 05:11:36 PM
#126310   4 weeks left & no $2.5-Mil. LOI financing JPetroInc 05/29/17 09:37:14 AM
#126308   congrats getting an update from IR would be good JPetroInc 05/25/17 06:42:17 AM
PostSubject
© 2017 InvestorsHub.Com, Inc.